Quick Takeaways
- MORGAN STANLEY filed SCHEDULE 13G/A for Applied Therapeutics, Inc. Common Stock (APLT).
- Disclosed ownership: 2.5%.
- Date of event: 31 Jan 2025.
MORGAN STANLEY - 31 Jan 2025 SCHEDULE 13G/A Report for Applied Therapeutics, Inc. Common Stock (APLT)
- Filing Manager
- MORGAN STANLEY
- Reporting Manager
- Morgan Stanley
- Symbol
- APLT
- Shares outstanding
- 114,357,240 shares
- Disclosed Ownership
- 2,858,931 shares
- Ownership
- 2.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 07 Feb 2025, 16:13:10 UTC
- Date of event
- 31 Jan 2025
- Previous filing
- 03 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"MORGAN STANLEY disclosed 2.5% ownership in Applied Therapeutics, Inc. Common Stock (APLT) on 31 Jan 2025."
What Changed
- Previous schedule filing date: 03 Feb 2025.
- Current filing was accepted on 07 Feb 2025, 16:13.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | 2.5% | 2,858,931 | 0 | 2,858,631 | Christopher O'Hara | Authorized Signatory, Morgan Stanley | |
| Morgan Stanley Capital Services LLC | 2.3% | 2,667,759 | 0 | 2,667,759 | Christopher O'Hara | Authorized Signatory, Morgan Stanley Capital Services LLC |